InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Browse the complete record of transactions filed by Kisner Daniel l, 董事. Director active across 2 companies, notably Zynerba Pharmaceuticals, Inc.. Aggregated, 8 filings have been published. Activity tracked since 3 August 2021. The latest transaction was filed on 11 June 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 条申报中的 8 条
KISNER DANIEL L is an Administrateur and appears in 8 filings. The sampled filings run from 2021-08-05 to 2026-02-10 and the most frequent transaction nature is Attribution, with buy and sell amounts shown as EUR 0 in the sampled filings.